Drugs / DC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02529072 | Jan 2016 → Sep 2017 | astrocytoma (excluding glioblastoma), glioblastoma | Gary Archer Ph.D. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02529072 ↗ |
| Modality | Cell therapy | “Human CMV pp65-LAMP mRNA-pulsed autologous DCs” NCT02529072 ↗ |